Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.31 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17723535 | 0.92 | CYP1A2 (0.32) | — | |
| SCHEMBL2647730 | 0.66 | POLB (0.34) | — | |
| SCHEMBL7118968 | 0.66 | ATM (0.36) | ATM | |
| SCHEMBL2935553 | 0.65 | — | — | |
| SCHEMBL2935295 | 0.63 | — | — | |
| SCHEMBL11845645 | 0.62 | — | — | |
| SCHEMBL11313699 | 0.62 | — | — | |
| SCHEMBL6996440 | 0.62 | CYP1A2 (0.33) | ATM | |
| SCHEMBL16488105 | 0.62 | GABRA1 (0.35) | — | |
| SCHEMBL12680648 | 0.61 | ATM (0.33) | ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170226270-A1 | ENERGETIC COMPOUNDS AND COMPOSITIONS | TECHNOLOGY INNOVATION MOMENTUM FUND (ISRAEL) LIMITED PARTNERSHIP (IL) | 2017-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170226270-A1 | ENERGETIC COMPOUNDS AND COMPOSITIONS | GNA11, THEM6, TXN2 | PDE4A 2972/4885PDE4B 2142/4885PDE4C 2573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.